Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line
Open Access
- 29 March 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (25) , 2435-2450
Abstract
Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell lineKeywords
This publication has 66 references indexed in Scilit:
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivityin vitroandin vivoin colon cancer cell line modelsInternational Journal of Cancer, 2011
- Management of early gastrointestinal neuroendocrine neoplasmsWorld Journal of Gastrointestinal Endoscopy, 2011
- Cancer Cachexia: Mechanisms and Clinical ImplicationsGastroenterology Research and Practice, 2011
- The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancerWorld Journal of Surgical Oncology, 2010
- Neuroendocrine tumors of the small bowels are on the rise: Early aspects and managementWorld Journal of Gastrointestinal Endoscopy, 2010
- Ghrelin and leptin levels in cachectic patients with cancer of the digestive organsInternational Journal of Clinical Oncology, 2009
- Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancerCell and tissue research, 2008
- Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing miceBritish Journal of Cancer, 2006